Transcutaneous pacing: Difference between revisions
Alexgrohmann (talk | contribs) |
No edit summary |
||
| Line 24: | Line 24: | ||
*[[ACLS: Bradycardia]] | *[[ACLS: Bradycardia]] | ||
*[[Transvenous pacing]] | *[[Transvenous pacing]] | ||
==External Links== | |||
===Videos=== | |||
{{#widget:YouTube|id=ZMGHyjIAjUs}} | |||
==References== | ==References== | ||
Revision as of 00:57, 30 June 2021
Background
Indications
- Bradyarrythmias causing hemodynamic impairment:[1]
- Tachyarrhythmias causing hemodynamic impairment[1]
Procedure
False capture with visible phantom beats[2]
- Pad placement:
- Pad on apex of heart and on right upper chest
- Pad on lead V3 position and between left scapula and T-spine
- Set: HR 80, pacing threshold usually between 40-80 mA
- If hemodynamically unstable or with evidence of end organ poor perfusion start at 80 mA and titrate down as tolerated.
- Look for clear QRS complex and T-wave following pacer spike
- Check pulse to confirm mechanical capture
- Final current set 5-10 mA above threshold level for patient
See Also
External Links
Videos
{{#widget:YouTube|id=ZMGHyjIAjUs}}
References
- ↑ 1.0 1.1 Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. May 27 2008;117(21):e350-408
- ↑ "Transcutaneous Pacing (TCP): The Problem of False Capture". EMS 12 Lead. Retrieved 2019-01-31.